Comparison of contrast-enhanced CT-based response with PET assessment after first-line therapy for follicular lymphoma in the Phase III GALLIUM Study
Abstract
Published data show 18F-FDG PET-CT (PET) is predictive after first-line immunochemotherapy in advanced-stage symptomatic FL, and PET is now the recommended modality for response assessment. However, no large-scale prospective comparison of the value of standard contrast-enhanced CT vs PET response has been performed.